merck Archives | Koneksa Health

Koneksa Press Release KH007 Topline Results thumbnail image

Koneksa Announces Positive Topline Results from KH007 Study Evaluating Digital Measures of Parkinson’s Disease Progression

By Koneksa HealthNews

Study meets primary compliance endpoint, reinforcing the value of Koneksa’s integrated measurement platform and syndicated, precompetitive study model with partners Merck and Regeneron. Punta Gorda, FL — September 1, 2026 —Koneksa Health...

September 1, 2026

Koneksa Health Announces Poster Presentation at the American Society for Clinical Pharmacology and Therapeutics 2019 Annual Meeting

By Koneksa HealthNews

Findings validate the use of mHealth technologies in cardiovascular treatment NEW YORK, March 19, 2019 /PRNewswire/ — Koneksa Health, a private company that enables the biopharmaceutical industry to develop new...

March 19, 2019

merck

Koneksa Announces Positive Topline Results from KH007 Study Evaluating Digital Measures of Parkinson’s Disease Progression

Koneksa Health Announces Poster Presentation at the American Society for Clinical Pharmacology and Therapeutics 2019 Annual Meeting

Contact

Technical Support

Products

Solutions

Therapeutic Areas

Insights

Company

Search Koneksa